Signaling Pathway
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Cangrelor Tetrasodium is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggregate. It is a modified ATP derivative stable to enzymatic degradation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. | ||
|---|---|---|---|
| Targets |
|
| 目录号 | A17919 |
|---|---|
| 分子式 | C17H21Cl2F3N5Na4O12P3S2 |
| 分子量 | 864.27 |
| CAS号 | 163706-36-3 |
| SMILES | CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]3O[C@H](COP([O-])(OP([O-])(C(P([O-])([O-])=O)(Cl)Cl)=O)=O)[C@@H](O)[C@H]3O.[Na+].[Na+].[Na+].[Na+] |
| 其他名称 | Cangrelor Tetrasodium; AR-C69931MX; AR C69931MX; ARC69931MX |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 2 mg/mL (2.31 mM) | |
| Water | 87 mg/mL (100.66 mM) | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 11.57 mL | 57.85 mL | 115.7 mL |
| 0.5 mM | 2.31 mL | 11.57 mL | 23.14 mL |
| 1 mM | 1.16 mL | 5.79 mL | 11.57 mL |
| 5 mM | 0.23 mL | 1.16 mL | 2.31 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
